Service and Health Among Deployed Veterans
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Jul 1, 2016
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The aim of the study is to characterize the impact of deployment-related pollution exposures during the Post-9/11 Gulf War Era on current respiratory health using objectively ascertained and standardized physiologic and epidemiologic measures. The primary objective in support of this aim is to assess the association of cumulative exposure to PM2.5 during deployments to the U.S. bases and other locations in Central Asia (Afghanistan and Kyrgyzstan), Southwest Asia (Iraq, Kuwait, Qatar, and United Arab Emirates) and Africa (Djibouti) with current measures of pulmonary function. Secondary obje...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Served during the Post-9/11 Gulf War Era in a service branch that had land-based deployments (Air Force, Army, and Marine Corps)
- • Deployed to Afghanistan, Kyrgyzstan, Iraq, Kuwait, Qatar, United Arab Emirates, or Djibouti after October 1, 2001
- Exclusion Criteria:
- • Active duty at the time of recruitment
- • Impaired decision making capacity
- • No English language proficiency
- • Prisoners
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Decatur, Georgia, United States
San Diego, California, United States
Seattle, Washington, United States
Minneapolis, Minnesota, United States
Houston, Texas, United States
West Roxbury, Massachusetts, United States
Patients applied
Trial Officials
Eric Garshick, MD
Study Chair
VA Boston Healthcare System West Roxbury Campus, West Roxbury, MA
Paul D Blanc, MD MSPH
Study Chair
San Francisco VA Medical Center, San Francisco, CA
Susan P Proctor, DSc
Study Chair
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Vincent S. Fan, MD MPH
Study Chair
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials